HCA Healthcare, Inc. (HCA): A Bull Case Theory

We came across a bullish thesis on HCA Healthcare, Inc. on Valueinvesting subreddit by DividendKing47. In this article, we will summarize the bulls’ thesis on HCA. HCA Healthcare, Inc.'s share was trading at $334.32 as of July 25^th. HCA’s trailing and forward P/E were 14.04 and 13.32 respectively according to Yahoo Finance.

HCA Healthcare, the largest U.S. hospital operator, manages 190 hospitals nationwide and plans to expand further with $5.0–5.2 billion in 2025 capital expenditures to meet growing healthcare demand. Benefiting from a healthcare services industry projected to grow at a 4.9% CAGR through 2029, HCA targets raising its 27% market share to 29% by 2030. Its 2024 revenue reached $70.6 billion, with 2025 guidance of $74–76 billion, implying 6.2% growth at the midpoint, supported by $10.5 billion in free cash flow and a $140 billion enterprise value.

Growth will be driven by facility upgrades, outpatient services expansion, and technological integration, including EHRs and AI-enabled diagnostics, enhancing efficiency and patient outcomes. HCA’s strategic pivot toward outpatient care, alongside modernization of existing hospitals, positions it to capture an aging population’s increasing needs while mitigating inpatient reimbursement risks. Consolidation trends favor HCA’s acquisition-led growth, though competitive pressures from peers like Tenet Healthcare and Universal Health Services remain.

A conservative DCF analysis, using a 9% WACC and 1.25% terminal growth, values the enterprise at $167 billion, with equity of $127.5 billion or $529.79 per share—representing 58.5% upside. Risks include regulatory changes, labor shortages, and public scrutiny that could pressure margins and volumes, as well as macroeconomic headwinds that may delay elective procedures.

Nonetheless, HCA’s scale, robust free cash generation, and focus on operational efficiency offer resilience. Even amid industry headwinds, its expansion strategy and strong positioning provide an attractive investment opportunity, with substantial upside potential underpinned by conservative growth assumptions and disciplined capital allocation.

Previously, we covered a bullish thesis on Tenet Healthcare Corporation (THC) by BlackSwanInvestor in December 2024, which highlighted operational streamlining, debt reduction, and the rapid expansion of its high-margin Ambulatory Care segment. The company’s stock price has appreciated by approximately 21.7% since our coverage, as the thesis played out. The thesis still stands as Ambulatory Care growth drives value creation. DividendKing47 shares a similar view but emphasizes HCA Healthcare’s scale-driven expansion and capital allocation in the same healthcare services market.

HCA Healthcare, Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 74 hedge fund portfolios held HCA at the end of the first quarter which was 81 in the previous quarter. While we acknowledge the potential of HCA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure: None.